Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
22
NMPA:22
Drug Approvals
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249709
- Approval Date
- Dec 6, 2024
NMPA
Potassium Aspartate Injection
- Product Name
- 门冬氨酸钾注射液
- Approval Number
- 国药准字H20244837
- Approval Date
- Sep 10, 2024
NMPA
Terbutaline Sulfate Injection
- Product Name
- 硫酸特布他林注射液
- Approval Number
- 国药准字H20243587
- Approval Date
- Apr 24, 2024
NMPA
Multiple Electrolytes Injection（Ⅱ）
- Product Name
- 复方电解质注射液(Ⅱ)
- Approval Number
- 国药准字H20183470
- Approval Date
- Nov 27, 2023
NMPA
Bromhexine Hydrochloride Injection
- Product Name
- 盐酸溴己新注射液
- Approval Number
- 国药准字H20234075
- Approval Date
- Aug 29, 2023
NMPA
Tranexamic Acid Injection
- Product Name
- 氨甲环酸注射液
- Approval Number
- 国药准字H20233661
- Approval Date
- Jun 7, 2023
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20223490
- Approval Date
- Jul 7, 2022
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 盐酸罗哌卡因注射液
- Approval Number
- 国药准字H20223489
- Approval Date
- Jul 7, 2022
NMPA
Olprinone Hydrochloride Injection
- Product Name
- 盐酸奥普力农注射液
- Approval Number
- 国药准字H20223273
- Approval Date
- Apr 29, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found